Announcement on Obtaining Drug Registration Certificate
Filed with SSE · · 2 pages · Chinese
Shanghai Shyndec Pharmaceutical Co., Ltd. on 6ix
Earlier from Shanghai Shyndec Pharmaceutical
- Announcement on Wholly-owned Subsidiary's Drug Substance Obtaining Indian Registration Certificate
- Announcement on Resolutions of the 2025 Annual General Meeting
- Report for Q1 2026
- Announcement on Progress in Providing Guarantees for Subsidiaries
- Earnings Preannouncement for Q1 2026
Later from Shanghai Shyndec Pharmaceutical
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Obtaining Drug Registration Certificate by Subsidiary
- Announcement on Holding Subsidiary Obtaining Drug Registration Certificate
- Announcement on Resolutions of the 5th Meeting of the 9th Board of Directors
- Semi-annual Performance Forecast for 2026
Follow Shanghai Shyndec Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Shyndec Pharmaceutical